Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Psoriasis with Sub-optimal Response to Prior Therapy
NCT00566722Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jan 2008
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Abbott Laboratories. Started Jan 2008; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00566722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00566722.